Delavirdine description

Revision as of 22:32, 1 January 2014 by Ahmed Zaghw (talk | contribs)
Jump to navigation Jump to search
Delavirdine
RESCRIPTOR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]


[1]

References

  1. ↑ "RESCRIPTOR (DELAVIRDINE MESYLATE) TABLET [VIIV HEALTHCARE COMPANY]". Retrieved 1 January 2014.

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Delavirdine_description&oldid=922524"